Physician profile
Cortney Casper
NPI 1811331663
$2,172.31
in general payments reported to CMS, 2019-2025
24 companies · $1,159 in 2025
The $1,159 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $160 · 2021: $77.23 · 2022: $145 · 2023: $290 · 2024: $342 · 2025: $1,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.14 |
| Travel and Lodging | $169.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $587.48 | 2020-2025 | Novasure, Fluent Fluid Management System, Acessa Provu System |
| Coloplast Corp | $559.64 | 2023-2025 | Altis, Saffron |
| Mayne Pharma Commercial LLC | $155.67 | 2023-2025 | |
| Astellas Pharma US INC | $136.90 | 2022-2025 | Veozah |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Abbvie INC. | $121.26 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.62 | 2020-2025 | |
| Sage Therapeutics, LLC | $64.92 | 2025 | Zurzuvae |
| Ethicon US, LLC | $34.78 | 2022 | |
| Organon LLC | $34.46 | 2022-2025 | Jada System |
| Exact Sciences Corporation | $32.51 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $30.71 | 2024-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $30.05 | 2020-2021 | |
| Coopersurgical, INC. | $29.18 | 2021-2024 | Paragard T 380a |
| Shield Therapeutics INC | $21.47 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $18.34 | 2024 | Slynd |
| Therapeuticsmd, INC. | $16.78 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.45 | 2025 | Qelbree |
| Mckesson Medical-Surgical, INC. | $15.95 | 2025 | |
| Minerva Surgical, INC | $14.80 | 2024 | |
| Biodelivery Sciences International, INC. | $14.56 | 2021 | |
| Allergan, INC. | $14.09 | 2020 | |
| Pfizer INC. | $13.34 | 2021 | |
| Avanos Medical | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cortney Casper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.